Commercialization

Development Strategies for Overcoming Commercialization Challenges

Matthias Lucke, Ph.D.

Coriolis Pharma

Recombinant Antibody

Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma

Suranjana Sen, Ph.D.

Sino Biological

Insect Cell Expression

Innovations in Baculovirus–Insect Cell Expression Systems

Amy Sheng, Ph.D.; Yingmin Zhu, Ph.D.; Xuejiao Zhang, Ph.D.

Sino Biological

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

Gene Tools

Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos

David Alvaro, Ph.D.; Jon Moulton, Ph.D.

Pharma's Almanac

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

Sumana Sundaramurthy, Ph.D.

Sino Biological

Computational Drug Design

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

Ronald Dorenbos, Ph.D.; Guido Lanza

Charles River Laboratories

Multispecific Antibodies

Optimized Multispecific Antibody Design, Development, and Manufacturing

Sino Biological

Recombinant Antibodies

Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing

Rob Burgess, Ph.D.; Amy Sheng, Ph.D.; Lilith Elmore

Sino Biological

Tissue Models

Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine

Liz Boazak, Ph.D.

Altis Biosystems

Tissue Models

Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity

Ron Laethem, Ph.D.

Altis Biosystems

Tissue Models

Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro

Bailey Zwarycz, Ph.D

Altis Biosystems

Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Ron Laethem, Ph.D.

Altis Biosystems

Drug Discovery

A Research Partner With Proven Results

Daniel Conlon

IRBM